SEC Form 4 · accession 0001209191-16-108500
Viking Therapeutics, Inc. · VKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Lian
Officer — President & CEO · Director
Period of report
Mar 14, 2016
Accepted (ET)
Mar 15, 2016 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001607678
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.88 | Mar 14, 2016 | A | 54,336 | A | Mar 14, 2016 | Mar 14, 2026 | Common Stock | 54,336 | 54,336 | D |
Explanation of responses
- F1The Reporting Person's employment agreement with the Issuer entitles him to an annual cash bonus. The Reporting Person voluntarily elected to be paid 50% of his 2015 annual cash bonus in the form of an option to purchase shares of common stock of the Issuer.